Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetesEric Kitas, Peter Mohr, Bernd Kuhn, et al.ACS Medicinal Chemistry Letters|June 22, 2019
Correction to "Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)"Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.ACS Medicinal Chemistry Letters|September 28, 2018
Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.The Journal of Pharmacology and Experimental Therapeutics|January 30, 2007
The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db miceEffie Tozzo, Randolph Ponticiello, JoAnn Swartz, et al.Bioorganic & Medicinal Chemistry Letters|April 29, 2006
Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4Christopher Blackburn, Bing Guan, James Brown, et al.Journal of Medicinal Chemistry|July 22, 2005
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesDavid J Augeri, Jeffrey A Robl, David A Betebenner, et al.ACS Medicinal Chemistry Letters|January 21, 2017
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic AgonistsJason M Cox, Hong D Chu, Mariappan V Chelliah, et al.Science (New York, N.Y.)|July 15, 2017
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophyRobert W Myers, Hong-Ping Guan, Juliann Ehrhart, et al.Pageof 2